These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 32407980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Assessment of chemical effects on aromatase activity using the H295R cell line.
    Higley EB, Newsted JL, Zhang X, Giesy JP, Hecker M.
    Environ Sci Pollut Res Int; 2010 Jun; 17(5):1137-48. PubMed ID: 20087668
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program.
    Borgert CJ, Mihaich EM, Ortego LS, Bentley KS, Holmes CM, Levine SL, Becker RA.
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):185-91. PubMed ID: 21803110
    [Abstract] [Full Text] [Related]

  • 7. Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.
    Browne P, Noyes PD, Casey WM, Dix DJ.
    Environ Health Perspect; 2017 Sep 01; 125(9):096001. PubMed ID: 28934726
    [Abstract] [Full Text] [Related]

  • 8. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ, Coady KK, O'Connor JC, Nabb DL, Markell LK, Snajdr S, Sue Marty M.
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb 01; 101(1):23-42. PubMed ID: 24515815
    [Abstract] [Full Text] [Related]

  • 9. A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study.
    Paul Friedman K, Papineni S, Marty MS, Yi KD, Goetz AK, Rasoulpour RJ, Kwiatkowski P, Wolf DC, Blacker AM, Peffer RC.
    Crit Rev Toxicol; 2016 Oct 01; 46(9):785-833. PubMed ID: 27347635
    [Abstract] [Full Text] [Related]

  • 10. Hypothesis-driven weight of evidence evaluation indicates styrene lacks endocrine disruption potential.
    Borgert CJ.
    Crit Rev Toxicol; 2023 Feb 01; 53(2):53-68. PubMed ID: 37216681
    [Abstract] [Full Text] [Related]

  • 11. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program.
    Bishop PL, Willett CE.
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb 01; 101(1):3-22. PubMed ID: 24151143
    [Abstract] [Full Text] [Related]

  • 12. Key lessons from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 male and female pubertal assays.
    Stump DG, O'Connor JC, Lewis JM, Marty MS.
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb 01; 101(1):43-62. PubMed ID: 24510766
    [Abstract] [Full Text] [Related]

  • 13. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals.
    Ankley GT, Gray LE.
    Environ Toxicol Chem; 2013 Apr 01; 32(5):1084-7. PubMed ID: 23401061
    [Abstract] [Full Text] [Related]

  • 14. Environmental signaling: from environmental estrogens to endocrine-disrupting chemicals and beyond.
    McLachlan JA.
    Andrology; 2016 Jul 01; 4(4):684-94. PubMed ID: 27230799
    [Abstract] [Full Text] [Related]

  • 15. Organochlorine pesticides: Agrochemicals with potent endocrine-disrupting properties in fish.
    Martyniuk CJ, Mehinto AC, Denslow ND.
    Mol Cell Endocrinol; 2020 May 01; 507():110764. PubMed ID: 32112812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chlorpyrifos: weight of evidence evaluation of potential interaction with the estrogen, androgen, or thyroid pathways.
    Juberg DR, Gehen SC, Coady KK, LeBaron MJ, Kramer VJ, Lu H, Marty MS.
    Regul Toxicol Pharmacol; 2013 Aug 01; 66(3):249-63. PubMed ID: 23524272
    [Abstract] [Full Text] [Related]

  • 18. Analysis of EPA's endocrine screening battery and recommendations for further review.
    Schapaugh AW, McFadden LG, Zorrilla LM, Geter DR, Stuchal LD, Sunger N, Borgert CJ.
    Regul Toxicol Pharmacol; 2015 Aug 01; 72(3):552-61. PubMed ID: 26044367
    [Abstract] [Full Text] [Related]

  • 19. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept.
    Becker RA, Friedman KP, Simon TW, Marty MS, Patlewicz G, Rowlands JC.
    Regul Toxicol Pharmacol; 2015 Apr 01; 71(3):398-408. PubMed ID: 25656492
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.